• Users Online: 74755
  • Home
  • Print this page
  • Email this page
This article has been cited by
1A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
Margriet I Van der Reis,Ellen C La Heij,Yvonne De Jong-Hesse,Peter J Ringens,Fred Hendrikse,Jan S A G Schouten
Retina.2011;31(8)1449
[DOI]
2Comparison of Intravitreal Triamcinolone Versus Bevacizumab in Bilateral Diabetic Macular Edema by Optical Coherence Tomography (OCT) Patterns
Sang Hyun Kim,Jung Min Park
Journal of the Korean Ophthalmological Society.2010;51(2)210
[DOI]
3Treatment of Refractory Diffuse Diabetic Macular Edema with Intravitreal Bevacizumab
M.M El Shafei,A Pai,M Al Hashimi,F Warid,M Farouk
Qatar Medical Journal.2011;2011(1)210
[DOI]
4INTRAVITREAL BEVACIZUMAB AS AN ADJUNCT TO LASER FOR DIFFUSE DIABETIC MACULAR EDEMA
Shah Nawaz,Shaveta Shaveta,Ishfaq Ahmad Sofi,Tariq Querishi
Journal of Evolution of Medical and Dental Sciences.2015;4(82)14258
[DOI]
5Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema
Romualdo Malagola,Giovanni Spinucci,Carmela Cofone,Luigi Pattavina
International Ophthalmology.2013;33(3)261
[DOI]
6Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema
J. Fernando Arevalo,Juan G. Sanchez,Lihteh Wu,Mauricio Maia,Arturo A. Alezzandrini,Miguel Brito,Sergio Bonafonte,Silvio Lujan,Manuel Diaz-Llopis,Natalia Restrepo,Francisco J. Rodríguez,Patricia Udaondo-Mirete
Ophthalmology.2009;116(8)1488
[DOI]
7Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
J. Fernando Arevalo,Juan G. Sanchez,Jans Fromow-Guerra,Lihteh Wu,Maria H. Berrocal,Michel E. Farah,Jose Cardillo,Francisco J. Rodríguez
Graefe's Archive for Clinical and Experimental Ophthalmology.2009;247(6)735
[DOI]
8Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
Alan G. Palestine
Graefe's Archive for Clinical and Experimental Ophthalmology.2020;247(6)350
[DOI]
9Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
Robert B. Nussenblatt
Graefe's Archive for Clinical and Experimental Ophthalmology.2010;247(6)355
[DOI]
10Diyabetik Makula Ödeminde Intravitreal Bevacizumab Tedavisinin Santral Makula Kalinligi Ve Santral Retina Duyarliligi Üzerine Etkisi
Hatice DALDAL,Yavuz BARDAKÇI
Ege Tip Bilimleri Dergisi.2020;3(2)59
[DOI]
11Meta-analysis and review on the effect of bevacizumab in diabetic macular edema
Sunali Goyal,Michael LaValley,Manju L. Subramanian
Graefe's Archive for Clinical and Experimental Ophthalmology.2011;249(1)15
[DOI]
12Meta-analysis and review on the effect of bevacizumab in diabetic macular edema
David J. Browning,Scott E. Pautler,David G. Telander,Keye Wong,Michael W. Stewart,Abdhish R. Bhavsar
Graefe's Archive for Clinical and Experimental Ophthalmology.2010;249(1)403
[DOI]
13Clinical outcomes and associated risk factors of cataract surgeries in patients with diabetic macular edema: A real-world study
ShikhaT Bassi,Shebin Salim,Ekta Rishi
Nigerian Journal of Vitreoretinal Diseases.2023;6(1)11
[DOI]
14Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema
Maria Douvali,Irini P. Chatziralli,Panagiotis G. Theodossiadis,Klio I. Chatzistefanou,Emmanouella Giannakaki,Alexandros A. Rouvas
Ophthalmologica.2014;232(3)136
[DOI]
15A STUDY ON THE SHORT TERM EFFECTS OF GRID LASER PHOTOCOAGULATION AND COMBINATION TREATMENT (GRID LASER WITH INTRAVITREAL BEVACIZUMAB) IN THE MANAGEMENT OF DIABETIC MACULAR OEDEMA
Adil Agarwal,Mary Thomas,Allen Shankar R,Shantha Sruthi M
Journal of Evolution of Medical and Dental Sciences.2016;5(36)2147
[DOI]
16Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
R. Simó,C. Hernández
Diabetologia.2008;51(9)1574
[DOI]
17Phacoemulcification with Intravitreal Bevacizumab Injection in Patients with Cataract and Coexisting Diabetic Retinopathy: Prospective Randomized Study
Ali Salehi,Afsaneh Naderi Beni,Hassan Razmjoo,Zahra Naderi Beni
Journal of Ocular Pharmacology and Therapeutics.2012;28(3)212
[DOI]
18Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy
Rizwan A. Cheema,Mahdi M. Al-Mubarak,Yasir M. Amin,Maheera A. Cheema
Journal of Cataract and Refractive Surgery.2009;35(1)18
[DOI]
19A review of clinical trials of anti-VEGF agents for diabetic retinopathy
Benjamin P. Nicholson,Andrew P. Schachat
Graefe's Archive for Clinical and Experimental Ophthalmology.2010;248(7)915
[DOI]
20TUNNELLED VERSUS STRAIGHT INTRAVITREAL INJECTION
PASCAL BRUNO KNECHT,STEPHAN MICHELS,VEIT STURM,MARTINA MONIKA BOSCH,MARCEL NICO MENKE
Retina.2009;29(8)1175
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal